MABs
Navigating the Pandemic With EUA Therapies
Infusion and specialty pharmacies have been playing a critical role in navigating a frequently changing menu of ...
AUGUST 23, 2022
FDA Limits Use of Monoclonal Antibodies to Treat COVID-19
The FDA revised the EUAs for two monoclonal antibody cocktails for COVID-19, essentially saying the should not be ...
JANUARY 25, 2022
Pharmacists Authorized to Order and Administer COVID-19 Therapeutics Under PREP Act Declaration
An amendment to the PREP Act broadly addresses the pharmacist's role in providing COVID-19 therapeutics, including ...
SEPTEMBER 16, 2021
FDA Authorizes Baricitinib Alone as COVID-19 Treatment
The FDA revised the emergency use authorization (EUA) for baricitinib to enable its use alone for the treatment of ...
JULY 29, 2021
FDA Authorizes Use of Actemra for COVID-19
The FDA issued an EUA Actemra to treat hospitalized adults and children who are receiving systemic corticosteroids ...
JUNE 28, 2021
FDA Revokes EUA for Bamlanivimab Monotherapy for COVID-19; Still Authorized in Combination
Although the FDA revoked its EUA for bamlanivimab monotherapy, the agency said it could still be given ...
APRIL 21, 2021
Challenges to Uptake of Monoclonal Antibody Therapies for COVID-19: Lessons Learned
Issues identified in the introduction and uptake of monoclonal antibody therapies for COVID-19 offer key insights ...
APRIL 21, 2021